Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters

Showing 1,267 results.

Thumbnail for Comparative Efficacy of Carfilzomib-Based Versus Bortezomib-Based Regimens in Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Trials

MM - 1151

Comparative Efficacy of Carfilzomib-Based Versus Bortezomib-Based Regimens in Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Trials

Vasu Malhotra

Poster Presenter: Vasu Malhotra

Thumbnail for Characterization of Edema Adverse Events in the CADENZA Study of Pivekimab Sunirine (PVEK) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

AML - 1153

Characterization of Edema Adverse Events in the CADENZA Study of Pivekimab Sunirine (PVEK) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Naveen Pemmaraju

Poster Presenter: Naveen Pemmaraju

Thumbnail for The Effect of Bezuclastinib on the Pathobiology of Mastocytosis: Changes in Bone Marrow Mast Cells, Tryptase, and KIT p.D816V Variant Allele Frequency From the Pivotal Summit Trial

MPN - 1154

The Effect of Bezuclastinib on the Pathobiology of Mastocytosis: Changes in Bone Marrow Mast Cells, Tryptase, and KIT p.D816V Variant Allele Frequency From the Pivotal Summit Trial

Dana Longo

Poster Presenter: Dana Longo

Thumbnail for Leukemia Subtype-Specific Patterns of Tumor Lysis Syndrome-Induced Acute Kidney Injury: Incidence, Dialysis Requirement, Mortality, and Healthcare Burden

TCL - 1156

Leukemia Subtype-Specific Patterns of Tumor Lysis Syndrome-Induced Acute Kidney Injury: Incidence, Dialysis Requirement, Mortality, and Healthcare Burden

Krupa Savani

Poster Presenter: Krupa Savani

Thumbnail for Long-Term Safety With Iptacopan Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria: Pooled Analysis of Data From Phase 2 and 3 Studies and the Roll-Over Extension Program

MDS - 1159

Long-Term Safety With Iptacopan Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria: Pooled Analysis of Data From Phase 2 and 3 Studies and the Roll-Over Extension Program

Silvia Sanz, Nick Kuypers

Poster Presenter: Nick Kuypers

Thumbnail for Trends, Predictors, and Outcomes of Do-Not-Resuscitate Status Among Adults Hospitalized With Acute Myeloid Leukemia: A National Inpatient Sample Analysis, 2016-2022

AML - 1160

Trends, Predictors, and Outcomes of Do-Not-Resuscitate Status Among Adults Hospitalized With Acute Myeloid Leukemia: A National Inpatient Sample Analysis, 2016-2022

Ameerdad Khan

Poster Presenter: Ameerdad Khan

Thumbnail for The Effect of Bezuclastinib on the Pathobiology of Advanced Systemic Mastocytosis: Results from the Pivotal Apex Trial

MPN - 1161

The Effect of Bezuclastinib on the Pathobiology of Advanced Systemic Mastocytosis: Results from the Pivotal Apex Trial

Tram Le

Poster Presenter: Tram Le

Thumbnail for Reproductive Outcomes After Chemotherapy in Young Women With Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis

ABCL - 1163

Reproductive Outcomes After Chemotherapy in Young Women With Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis

Shreya Patel

Poster Presenter: Shreya Patel

Thumbnail for Cardiac Safety of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Real-World Propensity-Matched Comparison of Dasatinib, Nilotinib, and Imatinib

CML - 1166

Cardiac Safety of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Real-World Propensity-Matched Comparison of Dasatinib, Nilotinib, and Imatinib

Rukash Khan Niazi

Poster Presenter: Rukash Khan Niazi

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.